Latest filing published 13 Jan 2009 for RespireRx Pharmaceuticals Inc., €4,613.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by John F. Benedik span 2 companies, the busiest being RespireRx Pharmaceuticals Inc. and Aeroflex Inc. Between 21 August 2006 and 13 January 2009, the trades on record add up to 6 filings.
The open-market record is one-sided, with 5 purchases worth €21k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2009 to date brings 3 purchases and no sales.
Half of the purchases are above €4,613 and half below.
Most recently, on 13 January 2009, the filings show an open-market purchase worth €4,613 in RespireRx Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations